Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice
Ashish Sharma, Emiko Segawa, Xiaoying Chen, Sohui Park, Shoutang Wang, Riley E Irmen, Nicholas J Constantino, Chanung Wang, Michael F Kanan, Marco Colonna, Shannon L Macauley, Jocelyn Y Cheng, Ken Hatanaka, Margaret Moline, Erik S Musiek · 2026
Read Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice by Ashish Sharma, Emiko Segawa, Xiaoying Chen, Sohui Park, Shoutang Wang, Riley E Irmen, Nicholas J Constantino, Chanung Wang, Michael F Kanan, Marco Colonna, Shannon L Macauley, Jocelyn Y Cheng, Ken Hatanaka, Margaret Moline, Erik S Musiek (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13214429.txt.
Description
Ashish Sharma and a large team test in 2026 whether a licensed sleeping pill can also slow Alzheimer's-type brain damage in mice. The drug blocks orexin, a wakefulness signal, and poor sleep is known to raise levels of the amyloid protein that forms plaques.
Mice bred to develop plaques received the drug, a comparison sedative, or plain vehicle for several weeks, starting before or after plaques appeared. The orexin blocker improved sleep with less daytime drowsiness and prevented sticky fibrillar plaque build-up, while the comparison drug only trimmed early diffuse deposits. Brain immune cells clustered around plaques and ate more amyloid under the drug. Removing those cells erased the benefit entirely.
Catalog record
| CREATOR | Ashish Sharma, Emiko Segawa, Xiaoying Chen, Sohui Park, Shoutang Wang, Riley E Irmen, Nicholas J Constantino, Chanung Wang, Michael F Kanan, Marco Colonna, Shannon L Macauley, Jocelyn Y Cheng, Ken Hatanaka, Margaret Moline, Erik S Musiek |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |